logo

For the Inventor, By the Inventor

Longmont, CO, United States of America

Jan J Zygmunt

This inventor holds 30 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent, primarily in Chemical Synthesis. Top assignees: Napro Biotherapeutics, Inc., Pioneer Energy Inc., Tapestry Pharmaceuticals, Inc.. Active years: 1999-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jan J Zygmunt. Retrieved from https://idiyas.com/inventor/jan-j-zygmunt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 

% Patents Active = 53.3

 

Average Co-Inventor Count = 3.0

ph-index = 7

Forward Citations = 329(Granted Patents)


Location History:

  • Boulder, CO (US) (1999 - 2000)
  • Longmont, CO (US) (1999 - 2020)

Company Filing History:

goldMedal9 out of 33 
 
Napro Biotherapeutics, Inc.
 patents
silverMedal7 out of 30 
 
Pioneer Energy Inc.
 patents
bronzeMedal7 out of 23 
 
Tapestry Pharmaceuticals, Inc.
 patents
4. 5 out of 572 
 
University of Kansas
 patents
5. 2 out of 2 
 
Thinkvillage-Oip, LLC
 patents

Years Active: 1999-2020

Loading Chart...
Loading Chart...
Areas of Expertise:
Taxane Analogs
Chemical Synthesis
High Caloric Fuels
Prodrugs
Ethanol Fermentation
Ketenes
Diketene Intermediates
Paclitaxel Synthesis
Water Soluble Prodrugs
Lower Alkanes
Linguistic Assistance
Stable Isotope Labeling
30 patents (USPTO):Explore Patents
1. 10639293 - 9,10-α,α-OH-taxane analogs and methods for production thereof (2020-05-05),
2. 10238621 - 9,10-α,α-OH-taxane analogs and methods for production thereof (2019-03-26),
3. 9926245 - Fuels and chemicals from lower alkanes (2018-03-27),
4. 9820962 - 9, 10-α, α-oh-taxane analogs and methods for production thereof (2017-11-21),
5. 9656932 - Preparation of pentanol with ethanol derived from fermentation (2017-05-23),
6. 9611186 - Synthesis of high caloric fuels and chemicals via ketene and diketene intermediates (2017-04-04),
7. 9440898 - Preparation of pentanol with ethanol derived from fermentation (2016-09-13),
8. 9402824 - 9,10-α, α-OH-taxane analogs and methods for production thereof (2016-08-02),
9. 9080119 - Synthesis of high caloric fuels and chemicals including pentanol from coal, natural gas, and biomass (2015-07-14),
10. 9040757 - Synthesis of high caloric fuels and chemicals (2015-05-26),
11. 8962870 - 9, 10-α, α-OH-taxane analogs and methods for production thereof (2015-02-24),
12. 8927789 - Synthesis of high caloric fuels and chemicals (2015-01-06),
13. 8423526 - Linguistic assistance systems and methods (2013-04-16),
14. 8131714 - Linguistic assistance systems and methods (2012-03-06),
15. 7879904 - 9, 10-α,α-OH-taxane analogs and methods for production thereof (2011-02-01),

Title: The Innovative Work of Inventor Jan J Zygmunt from Longmont, CO

Introduction:

Jan J Zygmunt, a prolific inventor based in Longmont, CO, has made significant contributions to cancer treatment through his groundbreaking patents. With an impressive portfolio of 30 patents, Zygmunt's work focuses on developing effective methods for cancer therapy, particularly in the realm of taxane analogs.

Latest Patents:

Among Zygmunt's latest patents is the innovative "9,10-α,α-OH-taxane analogs and methods for production thereof." This patent introduces a method for cancer treatment by administering taxane compounds to patients. The process involves treating specific compounds with acid and other components to create potent anti-cancer agents.

Career Highlights:

Zygmunt has garnered experience and expertise working with renowned companies such as Napro Biotherapeutics, Inc. and Tapestry Pharmaceuticals, Inc. His tenure in these organizations has provided him with valuable opportunities to bring his inventions to fruition and contribute to the field of oncology.

Collaborations:

Throughout his career, Zygmunt has collaborated with esteemed professionals such as James D McChesney and James Ferrara. These collaborations have enriched his research endeavors and enabled him to develop novel approaches to cancer treatment.

Conclusion:

Jan J Zygmunt's dedication to innovating cancer treatment methodologies has positioned him as a leading figure in the field of medical research. His patents reflect a deep commitment to improving patient outcomes and advancing the forefront of oncological innovation. With a strong foundation in scientific research and a passion for creating impactful solutions, Zygmunt continues to drive progress in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…